Evoke Pharma (EVOK) Misses Q1 EPS by 51c

Evoke Pharma (NASDAQ: EVOK) reported Q1 EPS of ($0.51). Revenue for the quarter came in at $3.1 million.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Lantern Pharma (LTRN) files for 2.24M share offering by selling stockholders
• 22nd Century Group files prospectus for warrant share resale